European Lung Cancer Congress 2024
20 - 23 Mar 2024
Prague, Czech Republic
Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent
The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.
Review the current state-of-the-art in lung cancer therapy, update your knowledge in prevention, screening, detection and much more.
The European Lung Cancer Congress 2024 provides insights into the prevention, diagnosis, biology and multi-disciplinary management of thoracic malignancies. Learning objectives included updating knowledge in early detection, reviewing current state-of-the-art systemic management, the emerging contribution of precision medicine, genomics technologies and artificial intelligence.
Abstracts, slides, webcasts and ePosters are published!
ESMO Colloquium supported by Eli Lilly & Company
Optimising molecular diagnosis and precision therapy in patients with advanced NSCLC harbouring rare oncogenic translocations
Industry partners' Satellite Symposia
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.